CHAPTER 80 Peritonsillar Abscess Drainage
Peritonsillar abscess, an infection in the space between the palatine tonsil and the pharyngeal constrictors, is the most common deep infection or abscess of the head and neck. Approximately 45,000 cases of peritonsillar abscess occur annually in the United States, usually in patients in the second or third decade of life; it rarely occurs in immunocompetent children younger than 6 years of age. Symptoms include fever, malaise, severe sore throat, trismus, odynophagia, and dysphagia with drooling. The patient may be dehydrated from a lack of oral intake. Pain is often referred to the ear, and the patient may have a voice with muffled resonance known as a “hot potato” voice. Signs of peritonsillar abscess include nonexudative pharyngitis in the majority of cases, marked edema of the soft palate, and a fluctuant fullness of the tonsil, which is covered superiorly by a shiny membrane. The classic sign is deflection of the swollen uvula to the opposite side (Fig. 80-1). There is often inferior and medial displacement of the affected tonsil. Tender cervical adenopathy is usually present.
The initial treatment of all patients with peritonsillar abscess should include adequate pain relief, hydration, and antibiotics. There is no consensus on choice of antibiotics. Penicillin, clindamycin, or cephalosporins are all reasonable as a first choice. Use of oral penicillin in doses of 500 mg four times daily has resulted in reasonable cure rates. Some clinicians add metronidazole if the clinical response in 24 hours is less than expected. Other clinicians advocate combining steroids with antibiotics. A recent study of rural field hospitals in the Indian Health Service suggested that high-dose steroids combined with cephalosporins, intravenous hydration, and analgesia were effective in reducing the number of patients needing to be air-evacuated from remote locations (see Lamkin and Portt, 2006).
Historically, the surgical treatment of peritonsillar abscess has been either abscess tonsillectomy or incision and drainage. If untreated, the abscess can rupture, possibly resulting in laryngeal aspiration, pneumonia, sepsis, or death. An untreated abscess can also spread locally or hematogenously, causing extensive local infection or even meningitis. Patients with a peritonsillar abscess and a history of three episodes of tonsillitis in the past year should probably be sent for an abscess tonsillectomy. However, for those patients without recurrent tonsillitis, there is growing evidence that needle aspiration is the treatment of choice. Needle aspiration has been shown to have an 85% to 100% success rate. Of those patients who respond initially, only 10% will have a recurrence. A second needle aspiration should also have a high success rate. Patients who fail a second or third needle aspiration should probably have an abscess tonsillectomy. (Even those patients who respond to a third aspiration should probably have a tonsillectomy, especially if this is the third infection in a year; see Chapter 83, Tonsillectomy and Adenoidectomy). The small percentage of patients whose abscess fails to resolve with a needle aspiration should probably have an incision and drainage procedure or be referred to an otolaryngologist to rule out a possible pterygomaxillary space abscess. An algorithm for the management of peritonsillar abscess is shown in Figure 80-2. Considering that the incision and drainage technique is now typically reserved for more difficult cases, it is not surprising that the recurrence rate is slightly higher than in the past, ranging from 6% to 24%.
Figure 80-2 Algorithm for management of peritonsillar abscess. ENT, ear, nose, and throat; I&D, incision and drainage.